Kolexia
Monneur-Miramon Audrey
Oncologie médicale
Centre Paoli-Calmettes
Marseille, France
55 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Métastase tumorale Sarcomes Cancers du sein inflammatoires Prédisposition aux maladies Nausée Syndrome des loges Tumeurs stromales gastro-intestinales Hypertension intra-abdominale

Industries

Abbvie
2 collaboration(s)
Dernière en 2023
Amgen
2 collaboration(s)
Dernière en 2023
Leo Pharma
1 collaboration(s)
Dernière en 2020
VIATRIS MEDICAL
1 collaboration(s)
Dernière en 2022

Dernières activités

MOST plus: A Two-period, Multicenter, Randomized, Open-label, Phase II Study Evaluating the Clinical Benefit of a Maintenance Treatment Targeting Tumor Molecular Alterations in Patients With Progressive Locally-advanced or Metastatic Solid Tumors
Essai Clinique (Centre Léon-Bérard)   09 février 2024
Improved nationwide survival of sarcoma patients with a network of reference centers.
Annals of oncology : official journal of the European Society for Medical Oncology   19 janvier 2024
Efficiency of Imatinib Treatment After 10 Years of Treatment in Patients With Gastrointestinal Stromal Tumours (GIST) (Gist-Ten): Randomized, Multicentre, Phase II Study Evaluating the Interest of Imatinib Treatment Maintenance or Interruption After at Least 10 Years of Treatment in Patients With Locally Advanced/Metastatic Gastrointestinal Stromal Tumors (GISTs)
Essai Clinique (Centre Léon-Bérard)   31 août 2023
Mazabraud Syndrome Associated with McCune-Albright Syndrome: A Case Report and Literature Review.
Case reports in oncology   12 mai 2023
Pourquoi et comment l’unité "Hors Les Murs" de l’IPC a-t-elle été créée ?
Edimark   01 janvier 2023
Organisation du suivi des patients sous thérapie orale par l’unité "Hors Les Murs"
Edimark   01 janvier 2023
Neoadjuvant Chemotherapy for Breast Cancer: Evolution of Clinical Practice in a French Cancer Center Over 16 Years and Pathologic Response Rates According to Tumor Subtypes and Clinical Tumor Size: Retrospective Cohort Study.
Journal of surgery and research   14 septembre 2022
CSPG4 Expression in GIST Is Associated with Better Prognosis and Strong Cytotoxic Immune Response.
Cancers   03 mars 2022
Metastatic inflammatory breast cancer: survival outcomes and prognostic factors in the national, multicentric, and real-life French cohort (ESME).
ESMO open   22 juillet 2021
Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial.
Genome medicine   18 mai 2021